DBD vs VYX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
DBD
VYX
Investment Advisor Scores
VYX
Oct 02, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | DBD | VYX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.1655 | 6.9832 | VYX |
| PEG Ratio | 0 | 2.6842 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.7% | -20.8% | DBD |
| Earnings Growth | 34.2% | -60.8% | DBD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 61.3/100 | 71.8/100 | VYX |
| Profit Margin | 2.9% | 3.0% | VYX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DBD
MarkdownPrice below a falling SMA50 (slope -10.6%), weak momentum, RSI 42
VYX
MarkdownPrice below a falling SMA50 (slope -2.6%), weak momentum, RSI 39
Fundamentals Snapshot
| Metric | DBD | VYX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.0 | 6.7 |
| Trailing P/E | 20.3 | 25.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.2% |
| Gross Margin | 0.3% | 0.3% |
| Operating Margin | 0.1% | 0.0% |
| EPS | 3.02 | 0.27 |
| Dividend Yield | — | — |